Suppr超能文献

利用微生物作为药物:微生物生态系统疗法。

Using bugs as drugs: Microbial ecosystem therapeutics.

作者信息

Allen-Vercoe E, Petrof E O

机构信息

Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON.

Department of Medicine, Queen's University, Kingston, ON.

出版信息

Can Commun Dis Rep. 2015 Nov 19;45(Suppl 5):3-6. doi: 10.14745/ccdr.v41is5a01.

Abstract

The human gut harbours a dense and highly diverse microbial ecosystem-the microbiota-that plays an important role in the maintenance of health. Modern lifestyle practices, including widespread antibiotic use, have degraded microbiota diversity, compromising the integrity of this vital ecosystem and creating susceptibility to diseases such as infection. Treatment of patients to restore the diversity of the gut microbiota offers a logical solution to disease. Although fecal microbial therapy (FMT) has started to gain traction as an effective method to effect this restoration, it is not without risks and there are significant barriers to its implementation in the clinic. Some of the risks and challenges with FMT are addressed by microbial ecosystem therapeutics (MET), an alternative approach to FMT that uses selected, defined microbial ecosystems to redress microbiota balance and functionality. The time has come for the use of bugs as drugs.

摘要

人类肠道中栖息着一个密集且高度多样的微生物生态系统——微生物群,它在维持健康方面发挥着重要作用。包括广泛使用抗生素在内的现代生活方式,已经降低了微生物群的多样性,损害了这个重要生态系统的完整性,并使人易患感染等疾病。治疗患者以恢复肠道微生物群的多样性为疾病提供了一个合理的解决方案。尽管粪便微生物疗法(FMT)作为实现这种恢复的有效方法已开始受到关注,但它并非没有风险,而且在临床实施中存在重大障碍。微生物生态系统疗法(MET)解决了FMT的一些风险和挑战,MET是FMT的一种替代方法,它使用选定的、明确的微生物生态系统来纠正微生物群的平衡和功能。用微生物作为药物的时代已经到来。

相似文献

1
Using bugs as drugs: Microbial ecosystem therapeutics.利用微生物作为药物:微生物生态系统疗法。
Can Commun Dis Rep. 2015 Nov 19;45(Suppl 5):3-6. doi: 10.14745/ccdr.v41is5a01.
6
Recurrent Clostridium difficile infection and the microbiome.艰难梭菌反复感染与微生物群
J Gastroenterol. 2016 Jan;51(1):1-10. doi: 10.1007/s00535-015-1099-3. Epub 2015 Jul 8.

引用本文的文献

1
Microbiome as an Immunological Modifier.微生物群作为一种免疫调节剂。
Methods Mol Biol. 2020;2055:595-638. doi: 10.1007/978-1-4939-9773-2_27.

本文引用的文献

1
Weight gain after fecal microbiota transplantation.粪便微生物群移植后体重增加。
Open Forum Infect Dis. 2015 Feb 4;2(1):ofv004. doi: 10.1093/ofid/ofv004. eCollection 2015 Jan.
3
Burden of Clostridium difficile infection in the United States.美国艰难梭菌感染的负担
N Engl J Med. 2015 Feb 26;372(9):825-34. doi: 10.1056/NEJMoa1408913.
4
Treatment of Clostridium difficile infections.艰难梭菌感染的治疗
Infect Dis Clin North Am. 2015 Mar;29(1):93-108. doi: 10.1016/j.idc.2014.11.005. Epub 2015 Jan 5.
5
Clostridium difficile infection: risk factors, diagnosis and management.艰难梭菌感染:危险因素、诊断与管理
Curr Treat Options Gastroenterol. 2015 Mar;13(1):121-9. doi: 10.1007/s11938-014-0038-3.
6
Dietary effects on human gut microbiome diversity.饮食对人类肠道微生物群多样性的影响。
Br J Nutr. 2015 Jan;113 Suppl(Suppl 0):S1-5. doi: 10.1017/S0007114514004127. Epub 2014 Dec 11.
9
The gut microbiota and inflammatory bowel disease.肠道微生物群与炎症性肠病
Semin Immunopathol. 2015 Jan;37(1):47-55. doi: 10.1007/s00281-014-0454-4. Epub 2014 Nov 25.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验